COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Writing for S&P Global Market Intelligence, the author compiles a list of current areas of focus within the health sector in the wake of the COVID-19 pandemic. Included in the list is "drug pricing and access," where the author notes how the pandemic has exposed inequalities in access to medicines in low- and middle-income countries. Including a snapshot of the 2021 Access to Medicine Index ranking, Hallem explains that investors are working to ensure more equitable access to new health products, such as vaccines and treatments.

Click here to read the full article.